Welcome

We are Galapagos

We are scientists, entrepreneurs, and pioneers united around a single purpose: to transform patient outcomes through life-changing science and innovation for more years of life and quality of life for people around the world.

Pioneering for patients

We are a biotechnology company with operations in Europe and the U.S. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class small molecules and cell therapies in oncology and immunology.

Our goal is not just to meet current medical needs but to anticipate and shape the future of healthcare, ensuring that our innovations reach those who need them most.

Our Technology Platforms

Small Molecules

  • Excellence, speed, agility: fully-integrated, end-to-end in-house capabilities
  • Best-in-class strategy: validated targets to develop differentiated medicines
  • 25 years of experience: enhanced by external partnerships

Our Technology Platforms

Cell Therapy

  • Scalable, decentralized, fast: stem-like, early memory cells near patients in median 7 days vein-to-vein
  • High-yielding discovery engine: multi-targeting, next-generation cell therapies
  • Diversify and grow: through partnerships and M&A

LATEST PRESS RELEASES

STORIES OF PURPOSE

Pioneering for Patients, with Patients!

Patients and Carers

At Galapagos, we put patients’ care and well-being first and foremost.

Our goal is to improve patients’ quality of life through life-changing science and innovation.

Discover our commitment to pioneering for patients, with patients!